P

Inventor

WOLIN RONALD L

US52 patents
⚠️ This page may combine multiple inventors who share the name “WOLIN RONALD L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

21 patents
US5721236AFeb 24, 1998

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP72 citations96
US5719148AFeb 17, 1998

Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP92 citations96
US5696121ADec 9, 1997

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP50 citations96
US6365588B1Apr 2, 2002

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP22 citations92
US6242458B1Jun 5, 2001

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP25 citations92
US6100279AAug 8, 2000

Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

SCHERING CORP53 citations92
US6075025AJun 13, 2000

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP34 citations92
US5958939ASep 28, 1999

Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases

SCHERING CORP26 citations92
US5807853ASep 15, 1998

Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP18 citations92
US5728703AMar 17, 1998

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP34 citations92
US5703090ADec 30, 1997

Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP33 citations92
US5684013ANov 4, 1997

Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP35 citations92
US7507767B2Mar 24, 2009

Cannabinoid receptor ligands

SCHERING CORP8 citations84
US7067539B2Jun 27, 2006

Cannabinoid receptor ligands

SCHERING CORP18 citations84
US6492381B1Dec 10, 2002

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP7 citations74
US6440989B2Aug 27, 2002

Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase

SCHERING CORP7 citations74
US6218401B1Apr 17, 2001

Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase

SCHERING CORP10 citations74
US6300338B1Oct 9, 2001

Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP1 citations63
US6130229AOct 10, 2000

Tricyclic compounds having activity as RAS-FPT inhibitors

SCHERING CORP3 citations63
US7718702B2May 18, 2010

Cannabinoid receptor ligands

SCHERING CORP5 citations62
US5977128ANov 2, 1999

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP2 citations62

JANSSEN PHARMACEUTICA NV

19 patents
US9290476B2Mar 22, 2016

Methylene linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV31 citations93
US9221804B2Dec 29, 2015

Secondary alcohol quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV35 citations93
US9309222B2Apr 12, 2016

Phenyl linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV13 citations82
US9403816B2Aug 2, 2016

Phenyl linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV3 citations73
US9346782B2May 24, 2016

Alkyl linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV3 citations73
US9328095B2May 3, 2016

Heteroaryl linked quinolinyl modulators of RORgammat

JANSSEN PHARMACEUTICA NV3 citations73
US10369146B2Aug 6, 2019

Phenyl linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV5 citations72
US9624225B2Apr 18, 2017

Quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV3 citations72
US9303015B2Apr 5, 2016

Heteroaryl linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV4 citations72
US9284308B2Mar 15, 2016

Methylene linked quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV6 citations71
US11254673B2Feb 22, 2022

Small molecule inhibitors of NF-κB inducing kinase

JANSSEN PHARMACEUTICA NV2 citations69
US11827634B2Nov 28, 2023

Small molecule inhibitors of NF-kB inducing kinase

JANSSEN PHARMACEUTICA NV0 citations60
US10201546B2Feb 12, 2019

Quinolinyl modulators of RORγt

JANSSEN PHARMACEUTICA NV0 citations51
US8686142B2Apr 1, 2014

2-aminopyrimidine modulators of the histamine H4 receptor

JANSSEN PHARMACEUTICA NV0 citations51
US7915420B2Mar 29, 2011

Aryl piperidine amides

JANSSEN PHARMACEUTICA NV0 citations51
US10975037B2Apr 13, 2021

Phenyl substituted pyrazoles as modulators of RORγt

JANSSEN PHARMACEUTICA NV0 citations49
US9732087B2Aug 15, 2017

Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor

JANSSEN PHARMACEUTICA NV0 citations49
US11034658B2Jun 15, 2021

Pyridinyl pyrazoles as modulators of RORγT

JANSSEN PHARMACEUTICA NV0 citations48
US7754882B2Jul 13, 2010

Hexahydro-pyrrolo-isoquinoline compounds

JANSSEN PHARMACEUTICA NV0 citations48

ORTHO MCNEIL PHARM INC

3 patents

(unassigned)

2 patents

BREITENBUCHER J GUY

2 patents

CAI HUI

1 patent

JANSSEN PHARACEUTICA NV

1 patent

APODACA RICHARD

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.